We have located links that may give you full text access.
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Sequential pulse defibrillation in man: comparison of thresholds in normal subjects and those with cardiac disease.
Medical Instrumentation 1987 June
We compared the parameters describing the defibrillation threshold in patients with normal hearts and in patients with ischemic heart disease, using a special electrode system and sequential pulses of current. Twenty-eight patients consented to the study (mean age: 36.6 +/- 10.1 years; mean mass: 80.7 +/- 13.8 kg). Twenty-one patients underwent surgery for Wolff-Parkinson-White syndrome (relatively normal hearts). Six patients had a history of previous myocardial infarction and aneurysm or coronary artery disease; and one patient had been resuscitated from an episode of sudden death, without evidence of consequent myocardial damage. For 26 patients, defibrillation thresholds were determined intraoperatively by passing sequential pulses through a catheter electrode and epicardial mesh electrode. For 2 patients defibrillation thresholds were determined during electrophysiologic study, after ventricular fibrillation was induced by programmed stimulation, by passing sequential pulses through a catheter and skin-patch electrode. Parameters for sequential pulse defibrillation thresholds between the two groups did not differ appreciably. Total energy for patients with normal hearts averaged 9.9 +/- 6.3 J compared to 8.9 +/- 4.6 J for patients with cardiac disease. No patient with cardiac disease had defibrillation parameters that exceeded the range of the normal patients. These results suggest that the presence of cardiac disease may not significantly alter the parameters necessary for successful defibrillation when using sequential pulses for delivery of energy.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
Haemodynamic monitoring during noncardiac surgery: past, present, and future.Journal of Clinical Monitoring and Computing 2024 April 31
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app